zagociguat – Patient Worthy

source: shutterstock.com

Zagociguat for Mitochondrial Diseases Earns Orphan Drug Designation

Post author:Jessica Lynn
Post published:March 31, 2023
Post category:Mitochondrial Disease

In the United States, the FDA grants Orphan Drug designation to drugs or biologics intended to diagnose, prevent, or treat rare conditions (those affecting fewer than 200,000 people in…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More